Economic Evaluation Of Mirabegron Versus Antimuscarinic Treatments In Patients With Overactive Bladder From The Pespective Of The Spanish National Health Service
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1471
https://www.valueinhealthjournal.com/article/S1098-3015(15)03547-0/fulltext
Title :
Economic Evaluation Of Mirabegron Versus Antimuscarinic Treatments In Patients With Overactive Bladder From The Pespective Of The Spanish National Health Service
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03547-0&doi=10.1016/j.jval.2015.09.1471
First page :
A510
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
966